University Hospital, Basel, Switzerland: Hyponatremia trials
The registry lists 11 Hyponatremia studies with University Hospital, Basel, Switzerland as lead sponsor. 4 are open to participants now and 0 have results posted.
Phase 2 2Phase 3 2Phase 4 1No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Effect of Protein Supplementation and Fluid Restriction on Plasma Sodium Levels in Patients Undergoing Pituitary SurgeryRecruitingNCT07273630Not applicable
- Protein Supplementation in Hyponatremia Due to the Syndrome of Inappropriate AntidiuresisRecruitingNCT06821802Not applicable
- Validation of New Diagnostic Indices to Simplify Hyponatremia Therapy Assessment in Patients on Thiazide DiureticsRecruitingNCT06381934Not applicable
- Urinary Prostaglandin as a Potential Predictive Marker for Thiazide-induced HyponatremiaRecruitingNCT05542056
- Effects of Intravenous [Pyr1]Apelin-13 on Healthy Volunteers With Artificially Induced SIADCompletedNCT06277336Not applicable
- Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic HyponatremiaCompletedNCT04447911Phase 4
- Influence of Serum Sodium Levels on Bone Metabolism and Turnover in Hospitalized PatientsCompletedNCT04227301
- Targeted Correction of Plasma Sodium Levels in Hospitalized Patients With HyponatremiaCompletedNCT03557957Not applicable
- Effects of the SGLT2-inhibitor Empagliflozin on Patients With Chronic SIADH - the SANDx StudyCompletedNCT03202667Phase 2/3
- Effects of Empagliflozin an SGLT2-Inhibitor on Healthy Volunteers With Induced Hypotonic Hyponatremia - the DIVE StudyCompletedNCT02729766Phase 2/3
- Copeptin in the Differential Diagnosis of Dysnatremia in Hospitalized PatientsCompletedNCT01456533